|
|
 |
|
Viewing report
|
|
|
|
Colorectal Cancer or Colon Cancer Therapy Area Pipeline Report
Life Science Analytics, March 2009, Pages: 549
Life Science Analytics, Colorectal Cancer or Colon Cancer Therapy Area Pipeline Report contains detailed information on the colorectal cancer or colon cancer drug pipeline. This report provides insight into the pipeline status of colorectal cancer or colon cancer drugs by company and by stage as well as a summary of the latest news and developments in this area.
Scope of the report:
Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.
In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company’s full product pipeline and products by phase of development with regard to the therapy area.
Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.
Key benefits
- Understand a company’s strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.
- Keep track of your competitors and partners by better understanding their product pipeline.
- Monitor a company’s research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.
- Maintain a critical competitive advantage.
Customers who bought this item also bought
Cancer Colorectal Cancer or Colon Cancer
Emerging Therapeutics in the U.S. Colorectal Cancer Markets
Colorectal Cancer (CRC) Therapeutics - Global Strategic Business Report
Current and Future Therapies for Colorectal Cancer - A Therapeutic & Competitive Insight
Innovations in Oncology Diagnostics: Technological Advances, Growth Opportunities and Future Market Outlook
Disease Specific Markers Clinical Trial Analysis
Tumour Markers Clinical Trial Analysis
Innovations in Cancer: Novel Therapeutics, New Diagnostics and Future R&D Strategies
Medical Review Criteria Guidelines for Managing Care, 8th edition. (2009 Update)
Computed Tomography Systems Clinical Trial Analysis
Gastrointestinal Endoscopy Devices - Global Strategic Business Report
Large Pharma: 2004 A Year Of Progress
|
|
|
|
